I'm interested in conversations about and I want to talk about
Know exactly what you want?
Show search

Notification

Error

Chemotherapy vrs Radiotherapy

Email this conversation Print this conversation
User
Posted 14 Apr 2023 at 18:21

Healthy 54 years; Gleason 9; Staging T3b N1 M1.Metastatic spread to pelvis and evidence of skeletal metastasis (Right Rib) makes treatment option not straightforward. PMSA pet scan showed tracer focal on rib therefore oncologist dilemma whether high or low burden.  Oncologist today has proposed 4 options for consideration:

RT / HT

3rd Gen ARPI ( Enzalutamide or Apalutamide)

Docetaxel Chemotherapy

Docetaxel Chemotherapy + Darolutamide (3rd Gen ARPI)

Any advice on pros / concerns short and long term or expereince of treatments. Thanks

Edited by member 15 Apr 2023 at 08:42  | Reason: Not specified

User
Posted 15 Apr 2023 at 10:43
If you are being offered daralutimide and chemo as part of a trial, I would give that serious consideration. Men on trials are monitored more closely and, at the moment triplet therapy is only NICE approved for men with no mets but results are very good so hopefully will be just as effective for men with mets
"Life can only be understood backwards; but it must be lived forwards." Soren Kierkegaard

 
Forum Jump  
Email this conversation Print this conversation

Join the online community now.

Click through to become a member and gain access to support, information and real time replies.




MenuTop ▲
©2025 Prostate Cancer UK